跳至主要内容
临床试验/IRCT20121031011341N11
IRCT20121031011341N11招募中3 期

The efficacy of Fumaria parviflora L. versus gabapentin on uremic pruritus of patients undergoing hemodialysis: A randomized non-inferiority double-blinded active-controlled clinical trial

Shiraz University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • The hemodialysis patient who has uncontrollable pruritus and now at least 1 week doesn't use any antipruritus medication
  • who had pruritus for at least 6 weeks
  • patient must have normal range phosphor and potassium in the past month
  • Parathyroid Hormone (PTH) must be lower than 500
  • measured visual analogue scale (VAS) score must be four or more

排除标准

  • They do not have liver disease, a history of convulsions, or a specific skin disease that causes itching, and they do not have hemolytic blood disease.
  • Patients who complain of itching for the first time are not included in the study
  • If the patient was taking medication that interacted with gabapentin or Fumaria parviflora L., he was not included in the study
  • Those who are allergic to Fumaria parviflora L. or Gabapentin are not included in the study

研究者

相似试验